PurposeRetinoids have been shown to be effective in suppressing tumor development when chemical carcinogens such as N-nitroso-N-methylurea (NMU) and N-nitroso-N-ethylurea (NEU) were used to induce mammary tumors in a variety of animal models. However, the molecular mechanisms associated with the retinoid-mediated chemopreventive process, as linked to transcription factor NF-κB activation, for chemoprevention have not been elucidated. The purpose of this study was to determine the implications of NF-κB activation on the chemopreventive role of retinoids and their effect on cellular NF-κB activity that's induced by known alkylating chemical carcinogens such as NMU and NEU in human transfectant squamous cell carcinoma (SCC-13) cells.
Materials and MethodsThe activity of NF-κB, as regulated by chemical carcinogens and retinoids, was determined in cultured human SCC-13 keratinocytes that were transfected with the pNF-κB-SEAP-NPT plasmid; this permitted the expression of the secretory alkaline phosphatase (SEAP) reporter gene in response to the NF-κB activity, and the plasmid contained the neomycin phosphotransferase (NPT) gene, which confers resistance to geneticin. The reporter enzyme activity was measured using a fluorescence detection assay method.
ResultsAll-trans retinoic acid and 13-cis retinoic acid induced a reduction of NF-κB activity up to 64% and 65%, respectively, compared to the control. For the treatment of the human transfectant cells with chemical carcinogens, all-trans retinoic acid (5 mM) and 13-cis retinoic acid (5 mM) downregulated the cellular NF-κB activation up to 83% and 85% compared to the NF-κB activity that was upregulated by NMU (5µM) and NEU (5µM), respectively.
ConclusionThese results suggest that the chemopreventive effect of retinoids may be mediated by the downregulated activation of NF-κB and that retinoids are implicated in the activation of NF-κB in human skin cells.